Bridging Studies- A Key in the Extrapolation of Clinical Results between Regions

  • Rada Santosh Kumar GITAM Institute of Pharmacy, GITAM (Deemed to be University)
  • S. Aditya Srinivas

Abstract

In pharmaceutical industry, the sponsors are interested in bringing their drug products from one region (e.g., the United States of America) to another region (e.g., Asian Pacific) to increase the exclusivity of the drug products in the marketplace. However, it is about the clinical results that can be extended from the victim patient population in one region to a similar, but different patient population in a new region due to a possible difference in ethnic factors. The International Conference on Harmonization (ICH) suggested that a bridging study may be important to extrapolate the clinical results between regions. However, little or no information concerns the basis for determining whether a bridging study is necessary based on the assessment of the complete clinical data package provided by the ICH. Moreover no criteria on the evaluation of similarity of clinical results between regions is given.


Keywords: International Conference on Harmonization, Bridging study, Clinical trails

Downloads

Download data is not yet available.

Author Biographies

Rada Santosh Kumar, GITAM Institute of Pharmacy, GITAM (Deemed to be University)

GITAM Institute of Pharmacy, GITAM (Deemed To Be University) Rushikonda, Visakhapatnam-530045, Andhra Pradesh, India.

S. Aditya Srinivas

GITAM Institute of Pharmacy, GITAM (Deemed To Be University) Rushikonda, Visakhapatnam-530045, Andhra Pradesh, India.

Statistics
11 Views | 29 Downloads
How to Cite
Santosh Kumar, R., & Aditya Srinivas, S. (2019). Bridging Studies- A Key in the Extrapolation of Clinical Results between Regions. Journal of Drug Delivery and Therapeutics, 9(4-A), 751-753. https://doi.org/10.22270/jddt.v9i4-A.3480

Most read articles by the same author(s)

1 2 > >>